Doke Buurman

16 Chapter 1 References 1. Rettig, E.M. and G. D’Souza, Epidemiology of head and neck cancer. Surg Oncol Clin N Am, 2015. 24(3): p. 379-96. 2. Federatie Medisch Specialisten, Werkgroep normen voor oncologienetwerken, SONCOS NORMERINGSRAPPORT versie 10 (2022). Available from: https://demedischspecialist. nl/normeringsrapport-van-soncos. 3. Chow, L.Q.M., Head and Neck Cancer. N Engl J Med, 2020. 382(1): p. 60-72. 4. Ferlay, J., et al. Global Cancer Observatory: Cancer Today. Available from: https://gco. iarc.fr/today, accessed on [28.03.2023]. 5. IKNL. Nederlandse Kankerregistratie (NKR). Available from: iknl.nl/nkr-cijfers, accessed on [07-09-2022]. 6. Auperin, A., Epidemiology of head and neck cancers: an update. Curr Opin Oncol, 2020. 32(3): p. 178-186. 7. Dutch Cooperative Head & Neck Group (NWHHT), Policy head and neck cancer care 2013. (BELEIDSNOTITIE HOOFD-HALS ONCOLOGISCHE ZORG 2013). Available from: https://www.nwhht.nl/. 8. van Huizen, L.S., et al., Multidisciplinary first-day consultation accelerates diagnostic procedures and throughput times of patients in a head-and-neck cancer care pathway, a mixed method study. BMC Health Serv Res, 2018. 18(1): p. 820. 9. Edge, S.B. and C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010. 17(6): p. 1471-4. 10. Huang, S.H. and B. O’Sullivan, Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol, 2017. 18(7): p. 40. 11. Blanchard, E.M., et al., Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509. J Thorac Oncol, 2011. 6(1): p. 115-20. 12. Blanchard, P., et al., Meta-analysis of chemotherapy in head and neck cancer (MACHNC): a comprehensive analysis by tumour site. Radiother Oncol, 2011. 100(1): p. 33-40. 13. Bonner, J.A., et al., Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med, 2006. 354(6): p. 567-78. 14. Tang, J.A., J.M. Rieger, and J.F. Wolfaardt, A review of functional outcomes related to prosthetic treatment after maxillary and mandibular reconstruction in patients with head and neck cancer. Int J Prosthodont, 2008. 21(4): p. 337-54. 15. Vissink, A., et al., Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med, 2003. 14(3): p. 213-25. 16. Speksnijder, C.M., et al., Oral function after oncological intervention in the oral cavity: a retrospective study. J Oral Maxillofac Surg, 2010. 68(6): p. 1231-7. 17. Pace-Balzan, A., R.J. Shaw, and C. Butterworth, Oral rehabilitation following treatment for oral cancer. Periodontol 2000, 2011. 57(1): p. 102-17. 18. Speksnijder, C.M., et al., Mastication in patients treated for malignancies in tongue and/or floor of mouth: A 1-year prospective study. Head Neck, 2011. 33(7): p. 1013-20.

RkJQdWJsaXNoZXIy MTk4NDMw